Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 8/20 | 0.67 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.66 |
| ▸ | SELL | P14151 | 1/20 | 0.61 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
| ▸ | CD22 | P20273 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29532284 | 1.00 | MAG (0.67) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29580672 | 1.00 | MAG (0.67) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL31682896 | 0.97 | SIGLEC7 (0.66) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL31717084 | 0.95 | MAG (0.67) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29432525 | 0.95 | SIGLEC7 (0.67) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL6277035 | 0.95 | SIGLEC7 (0.67) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL31716429 | 0.94 | SELP (0.66) | MAGSIGLEC7SELLSELP | |
| SCHEMBL30970760 | 0.94 | SIGLEC7 (0.70) | MAGSIGLEC7SELLSELP | |
| SCHEMBL31700860 | 0.94 | SIGLEC7 (0.68) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL15177449 | 0.94 | MAG (0.69) | MAGSIGLEC7SELLSELPCD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4539679-A1 | USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF BIFIDOBACTERIA | DSM IP Assets B.V. (NL) | 2025-04-23 | — | — | EP | disclosed |
| EP-4539678-A1 | USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF LACTOBACILLI | DSM IP Assets B.V. (NL) | 2025-04-23 | — | — | EP | disclosed |
| WO-2023247577-A1 | USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF LACTOBACILLI | DSM IP ASSETS B.V. (NL) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023247578-A1 | USE OF HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING THE VIABILITY OF BIFIDOBACTERIA | DSM IP ASSETS B.V. (NL) | 2023-12-28 | — | — | WO | disclosed |